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Editor: Kevin V. ThomasThis study considers whether the current standard toxicokinetic methods are an accurate and applicable assess-
ment of xenobiotic exposure in an aquatic freshwater invertebrate. An in vivo exposure examined the uptake and
elimination kinetics for eight pharmaceutical compounds in the amphipod crustacean, Gammarus pulex bymea-
suring their concentrations in both biological material and in the exposure medium over a 96 h period. Selected
pharmaceuticals included two anti-inﬂammatories (diclofenac and ibuprofen), two beta-blockers (propranolol
and metoprolol), an anti-depressant (imipramine), an anti-histamine (ranitidine) and two beta-agonists
(formoterol and terbutaline). Kinetic bioconcentration factors (BCFs) for the selected pharmaceuticals were de-
rived from a ﬁrst-order one-compartment model using either the simultaneous or sequential modelling
methods. Using the simultaneous method for parameter estimation, BCF values ranged from 12 to 212. In con-
trast, the sequential method for parameter estimation resulted in bioconcentration factors ranging from 19 to
4533. Observed toxicokinetic plots showed statistically signiﬁcant lack-of-ﬁts and further interrogation of the
models revealed a decreasing trend in the uptake rate constant over time for rantidine, diclofenac, imipramine,
metoprolol, formoterol and terbutaline. Previous published toxicokinetic data for 14 organic micro-pollutantsKeywords:
Pharmaceuticals
Pesticides
Toxicokinetics
Bioconcentration
Invertebrates
397T.H. Miller et al. / Science of the Total Environment 547 (2016) 396–404were also assessed and similar trends were identiﬁed to those observed in this study. The decreasing trend of the
uptake rate constant over time highlights the need to interpret modelled data more comprehensively to ensure
uncertainties associated with uptake and elimination parameters for determining bioconcentration factors are
minimised.
© 2016 Elsevier B.V. All rights reserved.1. Introduction
The pseudo-persistent nature of pharmaceuticals and personal care
products (PPCPs) has beenhighlighted in recent years as an environmen-
tal concern and has led to the introduction of a watch list under the EU
Water Framework Directive which includes an anti-inﬂammatory,
diclofenac, and two hormones, the synthetic ethinyl-estradiol (EE2)
and natural estradiol (2013/39/EU, 2013). Several thousand PPCPs are
currently available worldwide and whilst measured environmental con-
centrations typically range from low ng L−1 to high μg L−1, their poten-
tial to effect an ecotoxicological response and/or bioaccumulate in a
range of biota still remains understudied (De Lange et al., 2006;
Contardo-Jara et al., 2011).
Ecotoxicological studies have shown thatmeasured PPCP concentra-
tions in surface waters would be highly unlikely to cause acute effects
on exposed organisms (Crane et al., 2006). However, chronic exposure
has been linked to behavioural activity changes, increased oxidative
stress and alterations to the function of several vital organs in ﬁsh and
invertebrates (Heckmann et al., 2007; Fernández et al., 2013). Aquatic
invertebrates such as molluscs and smaller crustacean species have
been previously utilised for monitoring PPCPs in the natural aquatic en-
vironment. Most recently, the freshwater amphipod, Gammarus pulex,
was found to contain residues of carbamazepine, diazepam, nimesulide,
trimethoprim and warfarin measuring at low ng g−1 concentrations in
UK streams (Miller et al., 2015). PPCP uptake has also been previously
observed at lowngg−1 concentrations inwild and cagedmussel species
collected from the coast of Ireland, the Bohai Sea in China, the Mediter-
ranean Sea and San Francisco Bay, highlighting the extent of PPCP con-
tamination worldwide (McEneff et al., 2014; Li et al., 2012; Bueno et al.,
2013; Klosterhaus et al., 2013). EU Directive 93/39/EEC requires an en-
vironmental risk assessment to be carried out prior to drug licencing in
order to determine any signiﬁcant toxicological risks associated with a
xenobiotic (Straub, 2002). Under the regulatory guidelines, environ-
mental toxicity testing of pharmaceuticals requires standard acute tox-
icity tests, such as LC50 testing, to be carried out unless the predicted
environmental concentration (PEC)/predicted no effect concentration
(PNEC) ratio is b1, whereby no further toxicity testing is required.
Standardised toxicity tests on aquatic organisms are generally limited
to algae (Desmodesmus subspicatus or Pseudokirchneriella subcapitata),
Daphnia magna and/or ﬁsh (e.g. Danio rerio) considered as good
model species from freshwater environments. Furthermore, a lack of
published research generally exists on the uptake and depuration kinet-
ics of PPCPs both in target and non-target aquatic species to help eluci-
date potential acute versus chronic effects.
Toxicokinetic studies identify whether a compound will accumulate
to potentially toxic levels in/on the organism itself over time or
potentially act as a source of toxicity in higher trophic organisms
(Ashauer & Escher, 2010). In aquatic species, this can involve the
study of either accumulation of compounds via water exposure only
(i.e. bioconcentration), or via exposure through both water and diet
(i.e. bioaccumulation or biomagniﬁcation) (Oliver & Niimi, 1983;
Meador et al., 1995). Fish exposure studies often allow a time period
for the compound of interest to reach steady-state within the organism,
where the rate of uptake is equal to the rate of depuration. However,
this time can vary considerably and has led to the application of kinetic
modelling where uptake and elimination rates are estimated and used
to derive a bioconcentration factor (BCF) (Veith et al., 1979). This factor
can be determined in two ways: (a) as a ratio of either the compound
concentrations in the organism and the water phase at steady-state, or(b) as the ratio of the uptake (k1) and elimination (k2) rate constants
(Kenaga, 1972). This approach has been widely evaluated in the litera-
ture. Earlier models, such as those for methylmercury in ﬁsh
(Norstrom et al., 1976) considered several variables including volume
of water passing the gills, assimilation across the gills and body weight
of the organism. More recent models have been developed to also ac-
count for water-phase and lipid-phase resistance, ﬁsh lipid content
and compound logKow (Veith et al., 1979; Gobas & MacKay, 1987;
Hendriks & Heikens, 2001). A widely known and accepted model used
to calculate the bioaccumulation of a compound in ﬁsh via aqueous
and dietary exposure is outlined in the Organisation for Economic Co-
Operation and Development (OECD) 305 guidelines (OECD, Test No.
305). These guidelines present two methods for estimation of k1 and
k2. The sequential method can be performed in one of two ways, a k2
value can be estimated by linear regression and then curve ﬁtting
methods are applied to ﬁnd k1. Alternatively, curve ﬁtting methods
can be used to estimate k2 ﬁrst which is then used to estimate k1. The si-
multaneous model calculates both k1 and k2 together and is considered
a potentially more reliable and realistic model for concurrent uptake
and elimination processes occurring in biological systems. Considering
the number of PPCPs available on the market that may require testing
under EU REACH legislation (European Commission, 2006), the time
scales (2 week acclimatisation followed by 28 days for the uptake
phase alone unless steady-state is achieved sooner) and number of or-
ganisms required for each test (n=4 per time-point for each exposure)
the testing regime to apply to all chemicals under REACHwould appear
unfeasible. Furthermore, current policy aims to reduce the number of
ﬁsh used for scientiﬁc research, thus current methods proposed such
as the OECD guidelines should account for this more ethical approach
(Carter et al., 2014; Browne, 2013). Several recent studies assessing
BCF have utilised shorter exposure times with experiments lasting
only 4–7 days using aquatic invertebrates as a means to assess the po-
tential for substance to bioaccumulate in aquatic organisms (Ashauer
et al., 2006; Meredith-Williams et al., 2012). These ecotoxicological
studies are important to direct future risk assessment and essential
when considering contaminant monitoring in water, sediment and
biota.
In the present study, an in vivo experiment was carried out to deter-
mine the uptake and depuration kinetics of environmentally relevant
(low μg·L−1) concentrations of several selected PPCPs in the common
freshwater invertebrate, G. pulex, using radioactive labels and liquid
scintillation analysis. Lastly, the OECD 305 guidelines currently used
for modelling of uptake and elimination kinetics in aquatic species are
critically evaluated for the ﬁrst time based on the results obtained
both in this study and other published works on micropollutants.
2. Materials and methods
2.1. Reagents, chemicals and consumables
Radio-labelled pharmaceuticals including 3H-propranolol hydro-
chloride (29.0 Ci mmol−1) were acquired from Amersham Biosciences.
3H-metoprolol (29.7 Ci mmol−1), 3H-formoterol (18.5 Ci mmol−1) and
3H-terbutaline (29.0 Ci mmol−1) were obtained from Vitrax. 14C-
ibuprofen (2.03 Cimmol−1) was obtained fromAmerican Radiolabelled
Chemicals Inc. (St Louis, US). 3H-ranitidine (2.5 Cimmol−1) was obtain-
ed from Moravek Biochemicals, 14C-diclofenac (0.063 Ci mmol−1) and
3H-imipramine hydrochloride (48.5 Ci mmol−1) from Perkin-Elmer.
All stock solutions were stored in ethanol. Hydrogen peroxide solution
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gen carbonate, magnesium sulphate, calcium sulphate, potassium chlo-
ride were purchased from Sigma (Dorset, UK). Tissue solubiliser
(Solvable™) and liquid scintillation cocktail (Hionic Fluor™) were pur-
chased from Fischer Scientiﬁc Ltd. (Loughborough, UK). Ultra-pure
water was obtained from a Millipore Milli-Q water puriﬁcation system
with a speciﬁc resistance of 18.2 MΩ·cm or greater (Millipore, Bedford,
MA, USA). 6-Well culture plates were obtained from VWR (Leicester-
shire, UK).
2.2. Sample collection and culture maintenance
G. pulexwere collected by kick-sampling from the River Cray, South-
East London, UK, 51°23′09.5″N 0°06′32.4″E. This site was previously
shown to have low pharmaceutical contamination in both collected sur-
face water and animal samples (Miller et al., 2015). The populations
were transported to the laboratory in 500 mL Nalgene™ ﬂasks ﬁlled
with surface water from the sample collection site. Populations were
rinsedwith artiﬁcial freshwater (AFW) and then acclimatised to labora-
tory conditions (as speciﬁed below) for aminimumof 7 days before any
exposure experiments were performed. AFW was prepared from
1.15 mM of NaHCO3, 0.50 mM MgSO4, 0.44 mM CaSO4 and 0.05 mM
of KCl dissolved in 20 L of ultra-pure water. This water was subsequent-
ly aerated for several hours to remove dissolved carbonic acid andmax-
imise the dissolved oxygen concentrations. Each culture tank (n = 8)
was ﬁlled with 2.5 L of AFW and animals were fed with alder leaves
that were previously collected from the sampling site and conditioned
by submersion in surface water for two days prior to use.
2.3. Toxicokinetic exposure and conditions
Toxicokinetic experiments were performed separately for each
pharmaceutical for a total of 96 h which included a 48 h uptake phase
followed by a 48 h depuration period. Individual adult organisms,
both male and female and each N5 mg wet weight, were placed in
each well of 6-well culture plates. G. pulex were carefully transferred
to well plates using blunt forceps to avoid any harm to the organisms
before exposure. A single well contained one organism in 10 mL of ex-
posuremedia (AFWand test compound) and only non-parasitised indi-
viduals were used (absence of Pomphorhynchus laevis indicated by the
lack of an orange dot on the dorsal side of the animal).G. pulexwere ex-
posed to individual PPCPs at a concentration of 1 μg·L−1, except for
diclofenac and ibuprofen which were present at 10 μg·L−1. The higher
exposure of these two compounds was due to the low activity of the ra-
diolabel. All exposure media contained b0.05% of solvent (ethanol). A
total of 33 organisms were used per exposure and were sampled
(n= 3/time-point) at 2, 5, 18, 24 and 48 h in the uptake phase followed
by the same time-points in the depuration phase. Along with G. pulex,
50 μL water was also sampled from each well for analysis of radioactiv-
ity. Each sampled organismwaswashed in 10mL of ultra-purewater for
10 s (n = 6) and gently blotted dry to remove any excess exposure
media and unbound compound to the cuticle of the animal. Organisms
were weighed after sampling to determine body mass and then trans-
ferred to scintillation tubes for tissue solubilisation. Three individual or-
ganisms were also exposed to unspiked AFW in culture plates and
sampled after 96 h in a control experiment to account for any back-
ground radiation. Additionally, for each experiment, threewellswithout
G. pulex were ﬁlled with exposure media to account for losses of the
compound by sorption to the walls of culture plates. Culture plates
were stored in sealedplastic containerswithwet tissue to prevent evap-
orative losses during the static exposure. The light cycle followed
12:12 h light:dark without a dusk/dawn transition period. All experi-
ments were performed in a temperature controlled room at 15 °C
(±2 °C) and water pH was also measured across each experiment at
8.2 ± 0.1.2.4. Sample preparation and liquid scintillation counting
Water samples (50 μL) collected from each exposure well were
added to 2 mL of Hionic Fluor liquid scintillation cocktail and counted
for radioactivity on a Beckman LS6500 instrument (Beckman Coulter,
Inc.). Sampled G. pulex individuals were placed in a scintillation tube
with 2 mL of tissue solubiliser and maintained at room temperature
(approx. 20 °C) for 96 h. Samples were shaken vigorously and then a
50 μL aliquot of the solubilised biotic extract was added to 2 mL of
Hionic Fluor to be counted. To account for any difference in counts
caused by colour quenching, hydrogen peroxide (200 μL) was added
to a previously counted biotic extract and re-analysed. No difference
in counts was observed with or without the presence of hydrogen per-
oxide, therefore, all other biotic samples were counted without the ad-
dition of hydrogen peroxide. In addition, chemiluminescence accounted
for b0.01% of the overall counts, and was therefore ignored.
2.5. Modelling bioconcentration factors
Parameter estimation of uptake rate constant (k1) and depuration
rate constant (k2) was performed using a curve ﬁtting algorithm via
Minitab statistical software (Minitab Ltd., Coventry, UK) and as outlined
in the OECD 305 Fish Bioconcentration Guidelines (OECD, Test No. 305).
The concentration of compound in the organism is assumed to follow
ﬁrst order kinetics and is expressed in Eq. (1),
dCorganism
dt
¼ k1  Cwater½ −k2  Corganism
  ð1Þ
where, dCorganism/dt is the rate of change in the concentration of a com-
pound within/on G. pulex (mg kg−1 day−1), k1 is the uptake rate con-
stant (L kg−1 day−1), k2 is the elimination rate constant (day−1),
Cwater is the concentration in the water (mg L−1) and Corganism is the
concentration in the organism (mg kg−1). Eq. (1) was integrated into
Eqs. (2) and (3) for ﬁtting of curves to the uptake and depuration
data. This method, known as the Levenberg–Marquardt algorithm,
uses an iterative formula to minimise the residual errors between the
observed and predicted data points and simultaneously estimates k1
and k2 values from the ﬁtted curve i.e.
Corganism
  ¼ Cwater½   k1k2  1−e
−k2t
 
; when0btbte ð2Þ
Corganism
  ¼ Cwater½   k1k2  1−e
−k2 t−teð Þ−e−k2t
 
; when tNte ð3Þ
where, t is the time (days) and te is the end time of the uptake phase
(days). At steady-state, the rate of uptake should be equal to the rate
of depuration and there should be no overall change in analyte concen-
tration within G. pulex, as expressed by Eq. (4),
k1  Cwater½  ¼ k2  Corganism
 
↔
k1
k2
¼ Cfish½ 
Cwater½  ¼ BCF ð4Þ
where, BCF is the bioconcentration factor (L kg−1). BCF can also be esti-
mated using a sequential method where a simple linear regression
model is developed based on the depuration data only. With the as-
sumption of ﬁrst order kinetics, the model should ﬁt a straight line
and its slope represents the elimination rate constant as shown in
Eq. (5), i.e.
ln Corganism
  ¼−k2  t þ c ð5Þ
where, ln[Corganism] is thenatural log of the analyte concentrationwithin
G. pulex and c is the intercept, which here equals the natural log of the
analyte concentration in the G. pulex at the start of the depuration
phase. The k2 from Eq. (5) can then be used as a parameter in the
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399T.H. Miller et al. / Science of the Total Environment 547 (2016) 396–404curve ﬁtting algorithm to estimate k1. The rearrangement of Eq. (2) al-
lows the value for k1 to be calculated over the time interval speciﬁed,
as shown in Eq. (6) (Crookes & Brooke, 2011). The assumptions of the
equation are that analyte concentration in thewater and k2 remain con-
stant. The k2 used in Eq. (6) was directly estimated by using linear re-
gression of the depuration data to obtain the slope (k2). The value of
k1 should remain constant over the entire experiment.
k1 ¼
Corganism
  k2
Cwater½   1−e−k2t
  ð6Þ
For this study, initial parameters for k1 and k2 were arbitrarily set at
0.1 in the software with Cwater set in μg L−1, t set at 48 h and the maxi-
mum number of iterations was set at 200 upon which optimised k1 and
k2 values were subsequently derived. Conﬁdence intervals (95%) were
plotted for curves and the overall model ﬁts were assessed. The lack-
of-ﬁt test was calculated in theMinitab software andwas used to assess
the ﬁt of the line by comparing the variation in response of the replicate
data. Lack-of-ﬁt was assessed at a signiﬁcance level of 0.05. Correlation
coefﬁcients (r2) were evaluated when the sequential method was used
to estimate k2. The distribution coefﬁcient (logD) was generated using
ACD Labs Percepta software for the interpretation of estimated BCF
values. All compound information is displayed in Table S2 of the SI.
3. Results and discussion
3.1. Uptake and elimination kinetics for selected PPCPs within G. pulex
The exposure concentration of each PPCP was selected to approxi-
mate the higher ranges of trace pharmaceutical occurrence in the aquat-
ic environment to maintain practically quantiﬁable limits for reliable
analysis (Miller et al., 2015; Hilton & Thomas, 2003; Thomas & Hilton,
2004). Considering that natural uptake and depuration are not separate
processes, the BCF values for the selected compounds were determined
using the simultaneous model described above (Table 1). Uptake of
each pharmaceutical was observed in G. pulex as early as 2 h from the
point of exposure. The highest residue concentrations measured in
G. pulex at the 48h timepointwere ibuprofen and diclofenac, potentially
corresponding to the elevated exposure concentrations of 10 μg L−1. All
other compounds exposed at 1 μg L−1 measured b80 ng g−1 ww after
48 h uptake (Fig. 1). The rate of PPCP uptake measured in the exposed
G. pulex corresponds to the decreases in PPCP concentration measured
in the spiked AFW. The largest decrease in PPCP concentration was ob-
served for imipramine, where analyte concentrations in the water de-
creased to an average of 0.478 μg L−1 corresponding to a 52.2% loss.
After 48 h, formoterol concentration also decreased in water by 15% to
an average of 0.85 μg L−1. The exposure concentrations of the remaining
compounds did not decrease by ≥10% (Fig. 2 and Table S1). Additional
sources of potential PPCP loss in the aqueous phase should be men-
tioned and include photolysis, volatilisation, metabolism by microor-
ganisms and sorption to the walls of the exposure well. Of these
processes sorption was accounted for by control wells with exposure
media only andwas shown to account for negligible losses inwater con-
centration except in the case of imipramine (Table S1).Within 2 h, there
was a 27% loss of imipramine and within 48 h the loss increased to 39%.
As quantiﬁcation was performed by LSC, any degradation products
resulting from transformation or photolysis would contribute towards
the total radioactivity and counted as the precursor compound. Howev-
er, it should be considered that these formed products may potentially
have different accumulation potentials and hence latent uptake and
elimination kinetics.
Following removal from the contaminated source, relatively high
elimination rates were measured for most of the selected compounds.
However, imipramine showed increased uptake (k1 =
1.408 L kg−1 day−1), but lower elimination (k2 = 0.007 day−1),
resulting in the highest BCF value measured at 212. Diclofenac has the
Fig. 1. Uptake and elimination data for PPCPs in G. pulex. Dashed lines indicate 95% conﬁdence limits.
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Fig. 2. Relationship of uptake rate constants (k1) over time for eight PPCPs (black circles) and the respective water concentrations (Cw) over time (crosses).
401T.H. Miller et al. / Science of the Total Environment 547 (2016) 396–404same logP value as imipramine at 4.4 (logD8.2 =−1.1) but attained a
signiﬁcantly lower BCF value of 14 due to its high rate of elimination.
Ibuprofen, another acidic drug with a logP of 3.5 (calculated
logD8.2 =−0.1), also had a low BCF value determined at 27. The BCF
values for the four compoundswith logP b 2. (i.e. metoprolol, ranitidine,terbutaline and formoterol) were determined between 12 and 17. Hy-
drophobicity is generally considered a major factor when determining
the bioaccumulation potential of a compound. However, uptake studies
related to pharmaceuticals in several species of plants, for example,
showed poor correlations between logDow and logBCF and especially
402 T.H. Miller et al. / Science of the Total Environment 547 (2016) 396–404so for ionised molecules (Wu et al., 2013). Low bioconcentration of the
selected PPCPs was in agreement with a study by Meredith-Williams
et al., in which toxicokinetic data for six pharmaceuticals within
G. pulexwas shown with the exception of ﬂuoxetine, a selective seroto-
nin reuptake inhibitor (BCF = 185,900) (Meredith-Williams et al.,
2012). In the cases of diclofenac, ibuprofen, imipramine and proprano-
lol, logP is similar (3.3–4.7). Therefore, using an uptake model based
on hydrophobicity, it would be logical to assume similar uptake rates.
A potential reason for their difference could be physicochemical in na-
ture, e.g. due to their anionic or cationic nature as well as the degree
of ionisation and logDow value (Erickson et al., 2006). It could also be
due to biological factors such as gill surface charge or the boundary
layer between the bulk water and the gill surface (Tao et al., 2001). Up-
take across the gill may also occur bymore than simple passive diffusion
for these ionic compounds and thus carriermediated transportmay also
have inﬂuence on the different ionic species (Sugano et al., 2010; Kell &
Oliver, 2014). The increased uptake constants of imipramine, proprano-
lol and formoterol are in agreement with reported gill cell permeabil-
ities to these compounds in the same order of
imipramine N propranolol N formoterol (Stott et al., 2015). The low con-
centrations of PPCP residues measured in the G. pulex and unspiked
AFW post-exposure highlights the ability for G. pulex to readily
metabolise and eliminate xenobiotics, as previously shown by Nyman
et al. (2014) and Ashauer et al. (2012). This evidence suggests there is
conservation of cytochrome P450 enzymes, similarly observed in
other aquatic invertebrate species (Solé & Livingstone, 2005).
3.2. Comparison of simultaneous versus sequential uptake and depuration
process models
Methods used for the calculation of BCF values in G. pulex are
summarised in Table 1 and also include uptake and elimination con-
stants (±standard error). Many of the toxicokinetic plots in Fig. 1 are
shown to have some lack-of-ﬁt. The p-value generated from a lack-of-
ﬁt test shows that in the simultaneous method there are 5 models
that have a statistically signiﬁcant lack-of-ﬁt indicating potentially inac-
curate and unreliable BCF values. It is possible that several large outliers
could inﬂuence the lack-of-ﬁt test, thus resulting in a statistical signiﬁ-
cance when potentially none exists. When using the simultaneous
method, if a poor ﬁt exists, then the sequential method should be inves-
tigated as a potential alternative. The linear regression of the depuration
phase data points gives a direct estimate of k2. The goodness-of-ﬁt is
interpreted by visual inspection of the linearity and the r2 (Fig. S1). Con-
sideration of the sequential method showed an over-estimation of BCF
values when compared to the simultaneousmodel. Deviations from lin-
earity can indicate higher order kinetics. Simple plots of 1/[Corganism]Table 2
Toxicokinetic parameters and standard errors (SE) for 14 organic micropollutants with biocon
Compound BAFa Simultaneous BCF
k1
(L kg−1 day−1)
SE k2
(day−1)
SE p-Valu
4-Nitrobenzyl chloride 185 666 665.740 4.540 4.540 0.000
2,4-Dichloroaniline 56 140 20.073 2.830 0.465 0.000
2,4-Dichlorophenol 4466 600 34.196 0.066 0.024 0.000
4,6-Dinitro-o-cresol 37 39 2.610 1.146 0.124 0.070
1,2,3-Trichlorobenzene 191 1142 403.773 10.648 3.781 0.513
2,4,5-Trichlorophenol 2635 941 79.280 0.252 0.064 0.001
Aldicarb 2 16 1.421 10.419 0.938 0.000
Carbofuran 65 10 0.355 0.146 0.019 0.026
Diazinon 82 276 24.271 3.569 0.3264 0.005
Ethylacrylate 87 110 12.139 1.594 0.2446 0.000
Hexachlorobenzene 2915 553 36.8714 0.221 0.046 0.000
Imidacloprid 7 2 0.093 0.265 0.038 0.000
Malathion 114 86 6.782 0.721 0.113 0.000
Sea nine 1732 755 57.821 0.303 0.065 0.000
a Reported from Ashauer et al. (2010).here did not indicate second order kinetics and therefore k2 values
from plots of ln[Corganism] were accepted. Low r2 values for some com-
pounds were likely due to the scatter in measured internal concentra-
tions. Comparison of derived k2 values showed that imipramine,
formoterol, ranitidine, diclofenac and terbutaline had signiﬁcantly
lower elimination constants in comparison to the simultaneous model
approach (Table 1). Markedly reduced estimations in k2 for imipramine
and ranitidine corresponded to a large increase in BCF for ranitidine, in-
creasing 4-fold, and imipramine, increasing N10-fold to ~4200 on aver-
age between curve ﬁtting and linear regression approaches. Given the
inherent non-standard method we have applied, further work would
be necessary to better understand this apparently high BCF and we
would caution reliance on this value from such a limited study. When
using a curve ﬁtting method to calculate an elimination constant in
the sequential method there was good agreement between the linear
regression estimates of k2, indicating the estimate of k2 was correct.
The p-values for the curve ﬁts indicated that there was only one statis-
tical lack-of-ﬁt for the k2 value generated for ibuprofen. Uptake curves
displayed a poor ﬁt (as shown for imipramine concentration in
G. pulex, which was consistently under-estimated). In addition, uptake
constants in Table 1 speciﬁcally showed signiﬁcant lack-of-ﬁt for all
compounds except propranolol and formoterol (p-value N 0.05). In
ﬁtting the depuration data using the sequential approach, a zero to
mildly increasing slope was observed overall for metoprolol due to a
wider scatter of data. A k2 value could not therefore be calculated for
metoprolol. The potential for model uncertainty highlighted in this
study is signiﬁcant from a regulatory perspective, especially for com-
pounds such as imipramine that was determined to be accumulative
using the sequential method and non-accumulative using the simulta-
neous method (European Commission, 2006).
3.3. Assessment of k1, k2 and Cw constancy
The OECD 305 model makes several assumptions that Cw, k1 and k2
do not change over time. To assess the potential validity of the k1 con-
stancy assumption in the ﬁrst instance, k1 was derived at each time
point accordingly (Crookes & Brooke, 2011). It should be noted that a
potential limitation to this approach was that the equation to calculate
k1 uses the k2 estimate from the depuration phase, but this was deemed
sufﬁcient to identify any trends in any variation observed. As the lack-
of-ﬁt tests of the simultaneous method showed signiﬁcant lacks-of-ﬁt
a direct estimation of k2 from linear regression is used in Eq. (6) for sim-
plicity and increased reliability. When plotted against time (Fig. 2), a
clear reduction in k1 over the exposure period was observed (especially
for imipramine and diclofenac). Some random variance was also ob-
served, such as for propranolol, which resulted in a relatively constantcentrations factors and lack-of-ﬁt tests for each compound.
Sequential BCF
e BCF k1
(L kg−1 day−1)
SE p-Value k2
(day−1)
SE p-Value BCF
147 259 28.324 0.00 1.212 0.149 0.230 214
50 70 4.689 0.03 0.392 0.092 0.868 179
9050 750 48.646 0.00 0.010 0.018 0.400 72,728
34 37 1.595 1.00 0.729 0.077 0.033 51
107 167 32.257 0.06 0.475 0.300 0.986 351
3729 1091 109.906 0.21 0.131 0.039 0.001 8327
2 3 0.245 0.00 0.936 0.140 0.003 3
68 10 0.570 0.11 0.140 0.019 0.025 72
77 161 10.418 0.00 1.590 0.287 0.259 101
69 67 5.122 0.00 0.204 0.033 0.000 331
2505 631 56.518 0.00 0.152 0.031 0.637 4160
7 2 0.117 0.02 0.175 0.022 0.000 13
120 80 5.059 0.02 0.378 0.072 0.001 212
2491 950 69.141 0.05 0.123 0.020 0.084 7696
403T.H. Miller et al. / Science of the Total Environment 547 (2016) 396–404average k1 value of 0.58 (±0.23), as would be expected. The simulta-
neous and sequential models estimated its k1 value to be 0.54 and
0.62 L kg−1 day−1, respectively and therefore showed reasonable
agreement. This observation is signiﬁcant as propranolol showed no
lack-of-ﬁt in the uptake curve; therefore, the agreement indicates that
a lack-of-ﬁt arises from variable k1 values over time.
This suggests that a decreasing k1 trend is the cause of the poor
model ﬁts although it is possible that this may also be caused by a
changing k2 value (giving an apparent decrease in k1) or variable expo-
sure concentrations in the water. However, water was monitored dur-
ing the course of the experiments to account for any losses (Fig. 2 &
Table S1) and the only compound that showed any signiﬁcant loss
was imipramine (N20% nominal concentration). The k1 and k2 values
should also be independent of pharmaceutical concentrations in the
aqueous phase thus the trend observed is not in response to this vari-
able (van Leeuwen & Vermeire, 2007). A change in k2 is likely to be rep-
resented as a decrease over time (unless the compound induces its own
metabolism) assuming growth has a negligible effect and therefore
would not account for decreases in k1. The elimination curves also
showed no lack-of-ﬁt for 6 compounds and the linear regression
showed no trends of changing k2 values. The trend observed therefore
is not in response to the parameters Cw or k2 and we therefore suggest
the variability in uptake (decreasing k1) trend is the cause of the poor
model ﬁt.
3.4. Performance of OECD models using other micro-pollutant studies in
G. pulex
G. pulex has been shown tometabolise organic compounds with low
bioaccumulation factors previously observed (b1500) (Ashauer et al.,
2012). As deﬁned by Annex XIII of the REACH criteria, for a compound
to be considered bioaccumulative the BCF/BAF should be N2000
(European Commission, 2006). Other work by Ashauer et al. investigat-
ed the toxicokinetics of 14 micro-pollutants in G. pulex and presented
higher BCFs for three polychlorophenols in particular (Ashauer et al.,
2010). As discussed by the authors, correlations showed an observable
lack-of-ﬁt in some cases. A slightly different model to the OECD 305
model was used in this work, where changes in Cw were accounted
for as well as inclusion of an extra statistical algorithm to select the
best parameter combinations of k1 and k2. However, when applying
the OECD 305 models to BAF prediction, it is important to understand
whether this is likely to be inaccurate and, amongst other reasons, po-
tentially due to variation in k1, k2 or Cw. To determine if any similar
trends could be identiﬁed in other published G. pulex toxicokinetics
studies, raw data from Ashauer et al., was re-examined using the
OECD 305 modelling approach and presented in Table 2 (Ashauer
et al., 2010). Although the authors' experiments were originally de-
signed for determination of bioaccumulation, the report showed this
to account for a small percentage of accumulation. Therefore, feeding
was not included in any calculations. Similar to ourﬁndings for pharma-
ceuticals, both models displayed a statistically signiﬁcant lack-of-ﬁt for
these organic micro-pollutant compounds. When the sequential meth-
od was applied, better ﬁts were obtained for the depuration phase in
comparison to the uptake phase. However, despite models used herein
not performing as well overall, there was good agreement between the
predicted BCF values and those generated byAshauer et al. The datawas
then used to plot k1 versus time (Fig. S2), and again an obvious system-
atic decrease was observed for 9 out of 14 compounds. Statistical lack-
of-ﬁts (p b 0.05) were observed in the sequential uptake model espe-
cially for 4-nitrobenzylchloride, ethylacrylate, diazinon, aldicarb and
hexachlorobenzene (p b 0.001). The latter two compounds were nota-
ble cases where the spread of replicate k1 data at each time-point was
especially narrow and so the trend in k1 reduction over timewas appar-
ent. Of the remaining ﬁve compounds, trends in k1 were less evident
and were coupled with p N 0.05 for lack-of-ﬁt for four compounds
using the sequential uptake model. The remaining compound, 2,4-dichlorophenol, showed no obvious trends in k1 variance as the major
reason for the observed lack-of-ﬁt in the uptake phase. In summary, k1
data could be considered reliable for only 5 of 14 compounds using
the OECD 305 sequential model. In addition to the data of these 14 dif-
ferent organic pollutants, we also reassessed data from an exposure
study of chlorpyrifos across 15 different invertebrate species to assess
the issue more broadly (Rubach et al., 2010). Decreases in k1 were ob-
served in several species and the trend was somewhat similar, albeit
with larger scatter of the data (Fig. S3). This also identiﬁes a further lim-
itation thatmetabolism is likely to affect k1 and k2 values thus the differ-
ences in k1 constancy between organisms may be as a result of
biotransformation. The study showed considerable differences between
species in uptake and elimination rates showing that species type may
affect the constancy of k1 in particular and further studies are required
using more compounds between different species to fully assess this
possibility. If the assumption of k1 constancy varies on a compound-
by-compound basis, curve ﬁtting methods to predict BCF are likely to
be inherently inaccurate for environmental risk assessment purposes
for G. pulex. Therefore, it is suggested that the approach taken herein
(Crookes & Brooke, 2011) could be used to check the reliability of BCF
data where a statistical lack-of-ﬁt exists for this species.
Decreasing k1 could be explained by several possible mechanisms.
The ﬁrst is that growth dilution could cause an apparent decrease in
k1 due to the mass of the organism increasing while the concentration
of substance remains the same. However, this situation is unlikely
given the short timescales of this work and that of Ashauer et al.
(Ashauer et al., 2010). Therefore, growth of G. pulex is assumed to be
negligible, particularly as this is regulated in line with their moulting
cycle. However, further investigationwould be required to fully support
this. A second possibility is that G. pulex have been shown to alter respi-
ration rates in the presence of a poor diet (Graça et al., 1993). As the an-
imals were not fed during these experiments, it is possible that this
slowed uptake. However, the toxicokinetic experiments by Ashauer
et al. involved feeding organisms over their uptake period suggesting
the uptake trend is not in response to diet induced factors (Ashauer
et al., 2010). As these compounds are exposed to non-target animals,
it is also possible that toxicodynamic effects could affect uptake, which
is more easily interpreted using the dataset by Ashauer et al., where
the exposure concentration was between 2 and 88 fold below the 24 h
LC50 value. However for our dataset, mortality was not signiﬁcantly
higher than in controls for pharmaceuticals at the exposure concentra-
tions used. Another consideration is that instantaneous sorption to the
animal cuticle could account for the initially high k1 constants. However,
an examination of the decrease in uptake rate against logD and logP re-
vealed no correlation and compounds displayed independent k1 de-
creases (Fig. S4). However, logD only governs sorption to a certain
extent and other physicochemical properties including polar/topologi-
cal surface area, ionic state, amongst others, could inﬂuence sorption
onto the exoskeleton. Where animals shed their exoskeleton during
the exposure period, these were collected, weighedwet and radioactiv-
itymeasured in a brief experiment. It was found that themaximumcon-
centration of ﬁve of the eight pharmaceuticals on the exoskeleton
material recovered did not exceed 24% of total compound mass in the
animal in these cases (Table S3). Therefore, reduction in k1 via this
mechanism is indeed plausible, but extended measurements across
more compounds, conditions and replicates are recommended for full
characterisation of this process. The potential for sorption as the reason
for changes in k1 is not based on physiology, but rather on the physico-
chemical properties of the xenobiotic itself, suggesting that rate con-
stant stability may be compound speciﬁc.
4. Conclusions
This work demonstrates the importance of data interpretation using
multiple modelling methods to estimate BCFs. Speciﬁcally, the compar-
ative assessment of model lack-of-ﬁts for both simultaneous and
404 T.H. Miller et al. / Science of the Total Environment 547 (2016) 396–404sequential models (where k2 remains constant) is recommended to re-
liably estimate and to ensure the accuracy of xenobiotic risk assess-
ments. A decreasing trend in the uptake rate constant over time was
apparent which disrupted the validity of the standard model assump-
tions tested, and suggests that more complex models are needed to de-
scribe accumulation of xenobiotics in invertebrates,more particularly in
G. pulex. Kinetic BCF/BAF are an estimate of steady-state values, but it is
possible that these models are adequate enough to indicate whether a
compound may have a potential to accumulate or not. It is now impor-
tant to identify whether such trends are also observed more generally
across different species as well as a fuller investigation into the roles
sorption and metabolism have in these standard models.
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